EpiNet study of incidence of status epilepticus in Auckland, New Zealand: Methods and preliminary results
Corresponding Author
Peter S. Bergin
Auckland District Health Board, Auckland, New Zealand
Centre for Brain Research, University of Auckland, Auckland, New Zealand
Correspondence
Peter Bergin, Neurology Department, Auckland City Hospital, Auckland, New Zealand.
Email: [email protected]
Search for more papers by this authorAlice Brockington
Auckland District Health Board, Auckland, New Zealand
Sheffield Teaching Hospitals, National Health Service Foundation Trust, Sheffield, UK
Search for more papers by this authorJayaganth Jayabal
Auckland District Health Board, Auckland, New Zealand
Pantai-Gleneagles Hospital, Sungai Petani, Penang, Malaysia
Search for more papers by this authorShona Scott
Auckland District Health Board, Auckland, New Zealand
Western General Hospital, Edinburgh, UK
Search for more papers by this authorRhonda Litchfield
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorLynair Roberts
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorJerelyn Timog
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorErica Beilharz
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorStuart R. Dalziel
Auckland District Health Board, Auckland, New Zealand
Department of Surgery, University of Auckland, Auckland, New Zealand
Search for more papers by this authorPeter Jones
Auckland District Health Board, Auckland, New Zealand
Department of Surgery, University of Auckland, Auckland, New Zealand
Search for more papers by this authorKim Yates
Waitemata District Health Board, Auckland, New Zealand
Search for more papers by this authorVanessa Thornton
Counties Manukau District Health Board, Auckland, New Zealand
Search for more papers by this authorElizabeth B. Walker
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorBraden Te Ao
National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
Search for more papers by this authorPriya Parmar
National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
Search for more papers by this authorEttore Beghi
IRCCS Mario Negri Institute of Pharmacological Research, Milan, Italy
Search for more papers by this authorAndrea O. Rossetti
Department of Clinical Neurosciences, Vaud University Hospital Center and University of Lausanne, Lausanne, Switzerland
Search for more papers by this authorValery Feigin
National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
Search for more papers by this authorCorresponding Author
Peter S. Bergin
Auckland District Health Board, Auckland, New Zealand
Centre for Brain Research, University of Auckland, Auckland, New Zealand
Correspondence
Peter Bergin, Neurology Department, Auckland City Hospital, Auckland, New Zealand.
Email: [email protected]
Search for more papers by this authorAlice Brockington
Auckland District Health Board, Auckland, New Zealand
Sheffield Teaching Hospitals, National Health Service Foundation Trust, Sheffield, UK
Search for more papers by this authorJayaganth Jayabal
Auckland District Health Board, Auckland, New Zealand
Pantai-Gleneagles Hospital, Sungai Petani, Penang, Malaysia
Search for more papers by this authorShona Scott
Auckland District Health Board, Auckland, New Zealand
Western General Hospital, Edinburgh, UK
Search for more papers by this authorRhonda Litchfield
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorLynair Roberts
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorJerelyn Timog
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorErica Beilharz
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorStuart R. Dalziel
Auckland District Health Board, Auckland, New Zealand
Department of Surgery, University of Auckland, Auckland, New Zealand
Search for more papers by this authorPeter Jones
Auckland District Health Board, Auckland, New Zealand
Department of Surgery, University of Auckland, Auckland, New Zealand
Search for more papers by this authorKim Yates
Waitemata District Health Board, Auckland, New Zealand
Search for more papers by this authorVanessa Thornton
Counties Manukau District Health Board, Auckland, New Zealand
Search for more papers by this authorElizabeth B. Walker
Auckland District Health Board, Auckland, New Zealand
Search for more papers by this authorBraden Te Ao
National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
Search for more papers by this authorPriya Parmar
National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
Search for more papers by this authorEttore Beghi
IRCCS Mario Negri Institute of Pharmacological Research, Milan, Italy
Search for more papers by this authorAndrea O. Rossetti
Department of Clinical Neurosciences, Vaud University Hospital Center and University of Lausanne, Lausanne, Switzerland
Search for more papers by this authorValery Feigin
National Institute for Stroke and Applied Neurosciences, Auckland University of Technology, Auckland, New Zealand
Search for more papers by this authorSummary
The EpiNet project has been commenced to facilitate investigator-led collaborative research in epilepsy. A new Web-based data collection tool has been developed within EpiNet to record comprehensive data regarding status epilepticus and has been used for a study of status epilepticus in Auckland, New Zealand. All patients aged >4 weeks who presented to any of the five public hospitals and the major private hospital within Auckland city (population = 1.61 million) with an episode of status epilepticus between April 6, 2015 and April 5, 2016 were identified using multiple overlapping sources of information. For this study, status epilepticus was defined as any seizure exceeding 10 minutes in duration, or repeated seizures lasting >10 minutes without recovery between seizures. Patients who had either convulsive or nonconvulsive status epilepticus were included. Episodes of status epilepticus were classified according to the 2015 International League Against Epilepsy ILAE status epilepticus classification. A total of 477 episodes in 367 patients were considered as definite or probable status epilepticus; 285 episodes (62%) lasted >30 minutes, which is the duration that has previously been used for epidemiological studies of status epilepticus.
Supporting Information
Filename | Description |
---|---|
epi14478-sup-0001-FigS1.tiffTIFF image, 518.3 KB | |
epi14478-sup-0002-FigS2.tiffTIFF image, 357.3 KB | |
epi14478-sup-0003-FigS3.tiffTIFF image, 448.9 KB | |
epi14478-sup-0004-FigS4.tiffTIFF image, 363 KB | |
epi14478-sup-0005-FigS5.tiffTIFF image, 524.9 KB | |
epi14478-sup-0006-Legends.docxWord document, 10 KB |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
REFERENCES
- 1Trinka E, Kalviainen R. 25 years of advances in the definition, classification and treatment of status epilepticus. Seizure. 2017; 44: 65–73.
- 2Betjemann JP, Lowenstein DH. Status epilepticus in adults. Lancet Neurol. 2015; 14: 615–24.
- 3Trinka E, Hofler J, Leitinger M, et al. Pharmacotherapy for status epilepticus. Drugs. 2015; 75: 1499–521.
- 4Tan RY, Neligan A, Shorvon SD. The uncommon causes of status epilepticus: a systematic review. Epilepsy Res. 2010; 91: 111–22.
- 5Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011; 10: 922–30.
- 6Shorvon S. Guidelines for status epilepticus: are we there yet? Neurocrit Care. 2012; 17: 1–2.
- 7Shorvon S, Trinka E. The 5th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures. Epilepsy Behav. 2015; 49: 1–3.
- 8Bergin P, Frith R, Walker E, et al. How to get the answer to nearly everything: using the Internet for epilepsy research. Epilepsia. 2007; 48: 1415–1417; discussion 1417-24.
- 9Bergin P, Beghi E, Sadleir L, et al. EpiNet as a way of involving more physicians and patients in epilepsy research; validation study and accreditation process. Epilepsia Open. 2017; 2: 20–31.
- 10Bergin PS, Beghi E, Tripathi M, et al. Invitation to participate in the EpiNet-First trials. Epilepsia. 2015; 56: 807.
- 11Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus—report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015; 56: 1515–23.
- 12Lowenstein DH, Bleck T, Macdonald RL. It's time to revise the definition of status epilepticus. Epilepsia. 1999; 40: 120–2.
- 13Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med. 1998; 339: 792–8.
- 14Bergin P, Jayabal J, Walker E, et al. Use of the EpiNet database for observational study of status epilepticus in Auckland, New Zealand. Epilepsy Behav. 2015; 49: 164–9.
- 15Beghi E, Carpio A, Forsgren L, et al. Recommendation for a definition of acute symptomatic seizure. Epilepsia. 2010; 51: 671–5.